VCEL Short Volume
Vericel Corporation (VCEL) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.26B, listed on NASDAQ, employing roughly 398 people, carrying a beta of 1.07 to the broader market. Vericel Corporation operates as a biopharmaceutical firm that has reached the commercialization phase, specializing in the research, development, production, and distribution of cell-based treatments. Led by Dominick C. Colangelo, public since 1997-02-04.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-08-14
- Short Volume
- 70.7K
- Total Volume
- 105.8K
- Short %
- 66.89%
- 30-Day Avg Short %
- 57.92%
Showing 30 days of FINRA short volume data for Vericel Corporation.
Learn how short volume is reported and how to read the data →
Frequently asked VCEL short volume questions
- What is the daily VCEL short volume?
- As of Aug 14, 2026, Vericel Corporation (VCEL) short volume is 70.7K shares against 105.8K total reported volume, or 66.89% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is VCEL short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does VCEL short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.